Cite
APA Citation
Yuen, M., Agarwal, K., Gane, E. J., Schwabe, C., Ahn, S. H., Kim, D. J., Lim, Y., Cheng, W., Sievert, W., Visvanathan, K., Ruby, E., Liaw, S., Yan, R., Huang, Q., Colonno, R., & Lopatin, U. (2020). safety, pharmacokinetics, and antiviral effects of ABI-H0731, a hepatitis B virus core inhibitor: a randomised, placebo-controlled phase 1 trial. Lancet gastroenterology and hepatology, 5, 152–166. http://access.bl.uk/ark:/81055/vdc_100098804793.0x000001